FIGURE

Fig. S4

ID

ZDB-FIG-180627-15

Publication

Hayes et al., 2018 - Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma

Other Figures

All Figure Page

Back to All Figure Page

Fig. S4

Related to Figure 5. Transgenic expression of vangl2 does not affect tumor latency, incidence, or size in the primary zebrafish ERMS. (A-D) Zebrafish ERMS generated by injection of rag2:kRASG12D (A,B) or rag2:kRASG12D + rag2:vangl2 (C,D). rag2:GFP was co-injected to fluorescently label tumor cells. Representative images of tumor histology (B,D). (E) Tumor incidence assessed over time (n=175 animals for kRASG12D and n=214 animals for kRASG12D+Vangl2, p=0.57 log-rank statistic). (F) Tumor size measured at 30 days based on GFP intensity multiplied by 2D pixel area. Each datum point represents tumor size in a single fish. Not significant by Student’s t-test calculation (n.s.).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Stem Cell